Kangmei Pharmaceutical Co., LtdSSE: 600518

2025 Semi-annual Report

Aug 30, 2025 · Issued by Kangmei Pharmaceutical Co., Ltd via Shanghai Stock Exchange

Filed with SSE · Aug 30, 2025

On 6ix: 6ix.com/news/2025-semi-annual-report-61

2025 Semi-annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Kangmei Pharmaceutical Co., Ltd on 6ix

Earlier from Kangmei Pharmaceutical

Announcement on Result of the Application for Bankruptcy Liquidation of the Wholly-owned SubsidiaryAug 19, 2025
Announcement on Resolutions of the 3rd Extraordinary Meeting of the 10th Board of Directors in 2025Jul 18, 2025
Announcement on the Passive Formation of a Related Party Transaction Due to a Related Party's Acquisition of the Company's Creditor's RightsJul 5, 2025
Announcement on Progress of Litigation Enforcement by Subsidiaries (V)Jun 14, 2025
Announcement on Convening the 2024 Annual and Q1 2025 Performance BriefingMay 16, 2025

Later from Kangmei Pharmaceutical

Announcement on Receipt of Compensation PaymentOct 1, 2025
Announcement on Convening the 2025 Semi-annual Performance BriefingOct 10, 2025
Report for Q3 2025Oct 31, 2025
Announcement on Convening the Q3 2025 Performance BriefingNov 14, 2025
Notice on Convening the 2nd Extraordinary General Meeting in 2025Dec 11, 2025

All Kangmei Pharmaceutical news releases

Follow Kangmei Pharmaceutical into a list and get an email when it puts out news.

Follow Kangmei Pharmaceutical